Market Research Logo

Genomics Market Size, Share & Trends Analysis Report By Deliverables, By Application & Technology (Functional Genomics, Epigenomics), By End Use (Pharma & Biotech Companies), And Segment Forecasts, 2019 - 2025

Genomics Market Size, Share & Trends Analysis Report By Deliverables, By Application & Technology (Functional Genomics, Epigenomics), By End Use (Pharma & Biotech Companies), And Segment Forecasts, 2019 - 2025

The global genomics market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at a CAGR of 9.1% over the forecast period. The past decades have witnessed significant changes in disease management processes due to simultaneous advancements in genomics and personalized medicine. There has been a gradual growth in the usage of genomic studies in clinical practices, which is reflected by the rising trend of targeted therapies.

Results from genomic studies enable a better understanding of diseases and the underlying mechanisms for researchers, physicians, and patients. This facilitates evidence-based decision-making, and hence, helps improve personalized treatment regime. In addition, technological advancements in data analysis tools have motivated healthcare community to create precision-based therapies from surplus, available DNA data.

One of the most important factors, which are likely to have a significant impact on the market, is that how much and to what extent the medical community will make the use of available genomic information in personalized medicine. Furthermore, plummeting cost of sequencing has enabled the whole genome sequencing at very less price. Scientists are combining the sequencing generated data with diagnostics, which has proven its effectiveness in enhancing personalized treatment landscape.

The companies are involved in strategic alliances with global, as well as local, entities to boost their revenue generation and enhance their share in the market. For instance, in March 2017, Foundation Medicine collaborated with Bristol-Myers Squibb Company. This enabled Bristol-Myers Squibb to deploy Foundation Medicine’s molecular information solutions and comprehensive genomic profiling for identification of predictive biomarkers, such as Microsatellite Instability (MSI) and Tumor Mutational Burden (TMB), to accelerate its immunotherapy clinical trials.

Further key findings from the study suggest:

  • Growing interest of pharma and biotech companies in genomics is expected to drive the genomics market in coming years
  • NGS-based services held a major share of the market due to its rapid adoption in whole genome sequencing and application of sequence databases for disease screening and prognosis
  • The demand for these services would remain strong due to growing customer base from academic and research centers to CROs and biotech and pharma companies
  • Use of predictive biomarkers for diagnosis and monitoring takes cancer eradication a step further
  • Moreover, various organizations and programs are actively participating in the development of novel biomarkers for cancer diagnosis
  • With the rising health consciousness Direct-To-Consumer (DTC) laboratory testing is increasingly being employed. Such genetic tests enable consumers to access information about their genetics without having to visit healthcare professionals
  • Asia Pacific is the potential regional market for genomics. It is anticipated to expand at the highest CAGR of 11.2%
  • Major companies in the market include Beijing Genomics Institute (BGI); Agilent Technologies; Thermo Fisher Scientific, Inc.; Bio-Rad Laboratories, Inc.; Foundation Medicine, Inc.; 23andMe, Inc.; Danaher, Illumina, Inc.; Pacific Biosciences; Oxford Nanopore Technologies; F. Hoffmann-La Roche Ltd.; and Myriad Genetics, Inc.
Please note The report will be updated with the latest data and delivered to you within 3-4 business days.


Chapter 1 Research methodology
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing
Chapter 2 Executive Summary
2.1 Genomics Market Outlook, 2014 - 2025
Chapter 3 Industry Outlook
3.1 Penetration & Growth Prospects Mapping
3.2 Trend analysis
3.2.1 Application trends
3.2.2 Product trends
3.2.3 End-use trends
3.2.4 Regional trends
3.3 Genomics - Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Growing integration of genomics data into clinical workflows
3.3.1.1.1 More targeted and personalized healthcare
3.3.1.1.2 Growth of newborn genetic screening programs
3.3.1.1.3 Advancements in noninvasive cancer screening
3.3.1.1.4 Military genomics
3.3.1.2 Technological advances to facilitate genomic R&D
3.3.1.2.1 Emergence of advanced genome editing techniques
3.3.1.2.2 Integration of new data streams
3.3.1.2.3 RNA biology
3.3.1.2.4 Single cell biology
3.3.1.3 Rising adoption of direct to consumer genomics
3.3.1.4 Success of genetic tools in agrigenomics
3.3.1.5 Increasing participation of different companies
3.3.1.6 Increase in government role and funding in genomics
3.3.2 Market restraint analysis
3.3.2.1 Issues regarding intellectual property protection, data management, and public policies
3.3.2.2 Dearth of skilled personnel
3.4 Oppurtunity Analysis
3.5 Industry Analysis - Porter's
3.5.1 Supplier power - Medium
3.5.2 Buyer power - High
3.5.3 Substitution threat - Low
3.5.4 New entrants threat - Low
3.6 Regulatory landscape: Genomics - SWOT by PEST Analysis
3.6.1 Political landscape
3.6.2 Economic landscape
3.6.3 Social landscape
3.6.4 Technology landscape
3.7 Company market share analysis
3.8 Competitive landscape
3.8.1 Strategy framework
3.8.2 Company categorization
3.8.2.1 New entrants
3.8.2.2 Mature players & leaders
Chapter 4 Genomics Market Categorization: Deliverables Outlook
4.1 Genomics Market Share By Deliverabales Outlook, 2014 To 2025
4.2 Products Market, 2014 to 2025
4.2.1 Products market revenue, by North America (USD Million)
4.2.2 Products market revenue, by Europe (USD Million)
4.2.3 Products market revenue, by Asia Pacific (USD Million)
4.2.4 Products market revenue, by Latin America (USD Million)
4.2.5 Products market revenue, by Middle-East & Africa (USD Million)
4.2.6 Instruments/Systems market, 2014 to 2025, USD Million
4.2.6.1 Instruments/Systems market revenue, by North America (USD Million)
4.2.6.2 Instruments/Systems market revenue, by Europe (USD Million)
4.2.6.3 Instruments/Systems market revenue, by Asia Pacific (USD Million)
4.2.6.4 Instruments/Systems market revenue, by Latin America (USD Million)
4.2.6.5 Instruments/Systems market revenue, by Middle-East & Africa (USD Million)
4.2.7 Consumables/ Reagents, 2014 to 2025, USD Million
4.2.7.1 Consumables/ Reagents market revenue, by North America (USD Million)
4.2.7.2 Consumables/ Reagents market revenue, by Europe (USD Million)
4.2.7.3 Consumables/ Reagents market revenue, by Asia Pacific (USD Million)
4.2.7.4 Consumables/ Reagents market revenue, by Latin America (USD Million)
4.2.7.5 Consumables/ Reagents market revenue, by Middle-East & Africa (USD Million)
4.3 Services Market, 2014 to 2025
4.3.1 Services market revenue, by North America (USD Million)
4.3.2 Services market revenue, by Europe (USD Million)
4.3.3 Services market revenue, by Asia Pacific (USD Million)
4.3.4 Services market revenue, by Latin America (USD Million)
4.3.5 Services market revenue, by Middle-East & Africa (USD Million)
4.3.6 Core genomic services, 2014 to 2025
4.2.6.1 Core genomic services market revenue, by North America (USD Million)
4.2.6.2 Core genomic services market revenue, by Europe (USD Million)
4.2.6.3 Core genomic services market revenue, by Asia Pacific (USD Million)
4.2.6.4 Core genomic services market revenue, by Latin America (USD Million)
4.2.6.5 Core genomic services market revenue, by Middle-East & Africa (USD Million)
4.3.7 NGS based services, 2014 to 2025
4.3.7.1 NGS based services market revenue, by North America (USD Million)
4.3.7.2 NGS based services market revenue, by Europe (USD Million)
4.3.7.3 NGS based services market revenue, by Asia Pacific (USD Million)
4.3.7.4 NGS based services market revenue, by Latin America (USD Million)
4.3.7.5 NGS based services market revenue, by Middle-East & Africa (USD Million)
4.3.8 Biomarker translation services, 2014 to 2025
4.3.8.1 Biomarker translation services market revenue, by North America (USD Million)
4.3.8.2 Biomarker translation services market revenue, by Europe (USD Million)
4.3.8.3 Biomarker translation services market revenue, by Asia Pacific (USD Million)
4.3.8.4 Biomarker translation services market revenue, by Latin America (USD Million)
4.3.8.5 Biomarker translation services market revenue, by Middle-East & Africa (USD Million)
4.3.9 Computational services, 2014 to 2025
4.3.9.1 Computational services market revenue, by North America (USD Million)
4.3.9.2 Computational services market revenue, by Europe (USD Million)
4.3.9.3 Computational services market revenue, by Asia Pacific (USD Million)
4.3.9.4 Computational services market revenue, by Latin America (USD Million)
4.3.9.5 Computational services market revenue, by Middle-East & Africa (USD Million)
4.3.10 Other services, 2014 to 2025
4.3.10.1 Other services market revenue, by North America (USD Million)
4.3.10.2 Other services market revenue, by Europe (USD Million)
4.3.10.3 Other services market revenue, by Asia Pacific (USD Million)
4.3.10.4 Other services market revenue, by Latin America (USD Million)
4.3.10.5 Other services market revenue, by Middle-East & Africa (USD Million)
Chapter 5 Genomics Market Categorization: Technology - Application Outlook
5.1 Genomics Market Share By Technology - Application Outlook, 2014 To 2025
5.2 Functional Genomics, 2014 to 2025
5.2.1 Functional genomics market revenue, by North America (USD Million)
5.2.2 Functional genomics market revenue, by Europe (USD Million)
5.2.3 Functional genomics market revenue, by Asia Pacific (USD Million)
5.2.4 Functional genomics market revenue, by Latin America (USD Million)
5.2.5 Functional genomics market revenue, by Middle-East & Africa (USD Million)
5.2.6 Transfection, 2014 to 2025
5.2.6.1 Transfection market revenue, by North America (USD Million)
5.2.6.2 Transfection market revenue, by Europe (USD Million)
5.2.6.3 Transfection market revenue, by Asia Pacific (USD Million)
5.2.6.4 Transfection market revenue, by Latin America (USD Million)
5.2.6.5 Transfection market revenue, by Middle-East & Africa (USD Million)
5.2.7 Real time PCR, 2014 to 2025
5.2.7.1 Real time PCR market revenue, by North America (USD Million)
5.2.7.2 Real time PCR market revenue, by Europe (USD Million)
5.2.7.3 Real time PCR market revenue, by Asia Pacific (USD Million)
5.2.7.4 Real time PCR market revenue, by Latin America (USD Million)
5.2.7.5 Real time PCR market revenue, by Middle-East & Africa (USD Million)
5.2.8 RNA interference, 2014 to 2025
5.2.8.1 RNA interference market revenue, by North America (USD Million)
5.2.8.2 RNA interference market revenue, by Europe (USD Million)
5.2.8.3 RNA interference market revenue, by Asia Pacific (USD Million)
5.2.8.4 RNA interference market revenue, by Latin America (USD Million)
5.2.8.5 RNA interference market revenue, by Middle-East & Africa (USD Million)
5.2.9 Mutational analysis, 2014 to 2025
5.2.9.1 Mutational analysis market revenue, by North America (USD Million)
5.2.9.2 Mutational analysis market revenue, by Europe (USD Million)
5.2.9.3 Mutational analysis market revenue, by Asia Pacific (USD Million)
5.2.9.4 Mutational analysis market revenue, by Latin America (USD Million)
5.2.9.5 Mutational analysis market revenue, by Middle-East & Africa (USD Million)
5.2.10 SNP analysis, 2014 to 2025
5.2.10.1 SNP analysis market revenue, by North America (USD Million)
5.2.10.2 SNP analysis market revenue, by Europe (USD Million)
5.2.10.3 SNP analysis market revenue, by Asia Pacific (USD Million)
5.2.10.4 SNP analysis market revenue, by Latin America (USD Million)
5.2.10.5 SNP analysis market revenue, by Middle-East & Africa (USD Million)
5.2.11 Microarray analysis, 2014 to 2025
5.2.11.1 Microarray analysis market revenue, by North America (USD Million)
5.2.11.2 Microarray analysis market revenue, by Europe (USD Million)
5.2.11.3 Microarray analysis market revenue, by Asia Pacific (USD Million)
5.2.11.4 Microarray analysis market revenue, by Latin America (USD Million)
5.2.11.5 Microarray analysis market revenue, by Middle-East & Africa (USD Million)
5.3 Epigenetics, 2014 to 2025
5.3.1 Epigenetics market revenue, by North America (USD Million)
5.3.2 Epigenetics market revenue, by Europe (USD Million)
5.3.3 Epigenetics market revenue, by Asia Pacific (USD Million)
5.3.4 Epigenetics market revenue, by Latin America (USD Million)
5.3.5 Epigenetics market revenue, by Middle-East & Africa (USD Million)
5.3.6 Bisulfite sequencing, 2014 to 2025
5.3.6.1 Bisulfite sequencing market revenue, by North America (USD Million)
5.3.6.2 Bisulfite sequencing market revenue, by Europe (USD Million)
5.3.6.3 Bisulfite sequencing market revenue, by Asia Pacific (USD Million)
5.3.6.4 Bisulfite sequencing market revenue, by Latin America (USD Million)
5.3.6.5 Bisulfite sequencing market revenue, by Middle-East & Africa (USD Million)
5.3.7 Chromatin immunoprecipitation-sequencing (ChIP-Seq), 2014 to 2025
5.3.7.1 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by North America (USD Million)
5.3.7.2 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by Europe (USD Million)
5.3.7.3 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by Asia Pacific (USD Million)
5.3.7.4 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by Latin America (USD Million)
5.3.7.5 Chromatin immunoprecipitation-sequencing (ChIP-Seq) market revenue, by Middle-East & Africa (USD Million)
5.3.8 Methylated DNA immunoprecipitation (MeDIP), 2014 to 2025
5.3.8.1 Methylated DNA immunoprecipitation (MeDIP) market revenue, by North America (USD Million)
5.3.8.2 Methylated DNA immunoprecipitation (MeDIP) market revenue, by Europe (USD Million)
5.3.8.3 Methylated DNA immunoprecipitation (MeDIP) market revenue, by Asia Pacific (USD Million)
5.3.8.4 Methylated DNA immunoprecipitation (MeDIP) market revenue, by Latin America (USD Million)
5.3.8.5 Methylated DNA immunoprecipitation (MeDIP) market revenue, by Middle-East & Africa (USD Million)
5.3.9 High resolution melt, 2014 to 2025
5.3.9.1 High resolution melt market revenue, by North America (USD Million)
5.3.9.2 High resolution melt market revenue, by Europe (USD Million)
5.3.9.3 High resolution melt market revenue, by Asia Pacific (USD Million)
5.3.9.4 High resolution melt market revenue, by Latin America (USD Million)
5.3.9.5 High resolution melt market revenue, by Middle-East & Africa (USD Million)
5.3.10 Chromatin accessibility assays, 2014 to 2025
5.3.10.1 Chromatin accessibility assays market revenue, by North America (USD Million)
5.3.10.2 Chromatin accessibility assays market revenue, by Europe (USD Million)
5.3.10.3 Chromatin accessibility assays market revenue, by Asia Pacific (USD Million)
5.3.10.4 Chromatin accessibility assays market revenue, by Latin America (USD Million)
5.3.10.5 Chromatin accessibility assays market revenue, by Middle-East & Africa (USD Million)
5.3.11 Microarray analysis, 2014 to 2025
5.3.11.1 Microarray analysis market revenue, by North America (USD Million)
5.3.11.2 Microarray analysis market revenue, by Europe (USD Million)
5.3.11.3 Microarray analysis market revenue, by Asia Pacific (USD Million)
5.3.11.4 Microarray analysis market revenue, by Latin America (USD Million)
5.3.11.5 Microarray analysis market revenue, by Middle-East & Africa (USD Million)
5.4 Pathway Analysis, 2014 to 2025
5.4.1 Pathway analysis market revenue, by North America (USD Million)
5.4.2 Pathway analysis market revenue, by Europe (USD Million)
5.4.3 Pathway analysis market revenue, by Asia Pacific (USD Million)
5.4.4 Pathway analysis market revenue, by Latin America (USD Million)
5.4.5 Pathway analysis market revenue, by Middle-East & Africa (USD Million)
5.4.6 Bead-based analysis (Bio-Plex), 2014 to 2025
5.4.6.1 Bead-based analysis (Bio-Plex) market revenue, by North America (USD Million)
5.4.6.2 Bead-based analysis (Bio-Plex) market revenue, by Europe (USD Million)
5.4.6.3 Bead-based analysis (Bio-Plex) market revenue, by Asia Pacific (USD Million)
5.4.6.4 Bead-based analysis (Bio-Plex) market revenue, by Latin America (USD Million)
5.4.6.5 Bead-based analysis (Bio-Plex) market revenue, by Middle-East & Africa (USD Million)
5.4.7 Microarray analysis, 2014 to 2025
5.4.7.1 Microarray analysis market revenue, by North America (USD Million)
5.4.7.2 Microarray analysis market revenue, by Europe (USD Million)
5.4.7.3 Microarray analysis market revenue, by Asia Pacific (USD Million)
5.4.7.4 Microarray analysis market revenue, by Latin America (USD Million)
5.4.7.5 Microarray analysis market revenue, by Middle-East & Africa (USD Million)
5.4.8 Real time PCR, 2014 to 2025
5.4.8.1 Real time PCR market revenue, by North America (USD Million)
5.4.8.2 Real time PCR market revenue, by Europe (USD Million)
5.4.8.3 Real time PCR market revenue, by Asia Pacific (USD Million)
5.4.8.4 Real time PCR market revenue, by Latin America (USD Million)
5.4.8.5 Real time PCR market revenue, by Middle-East & Africa (USD Million)
5.4.9 Proteomics tools (2-D PAGE; yeast 2-hybrid studies), 2014 to 2025
5.4.9.1 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by North America (USD Million)
5.4.9.2 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by Europe (USD Million)
5.4.9.3 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by Asia Pacific (USD Million)
5.4.9.4 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by Latin America (USD Million)
5.4.9.5 Proteomics tools (2-D PAGE; yeast 2-hybrid studies) market revenue, by Middle-East & Africa (USD Million)
5.5 Biomarker Discovery, 2014 to 2025
5.5.1 Biomarker Discovery market revenue, by North America (USD Million)
5.5.2 Biomarker Discovery market revenue, by Europe (USD Million)
5.5.3 Biomarker Discovery market revenue, by Asia Pacific (USD Million)
5.5.4 Biomarker Discovery market revenue, by Latin America (USD Million)
5.5.5 Biomarker Discovery market revenue, by Middle-East & Africa (USD Million)
5.5.6 Mass spectrometry, 2014 to 2025
5.5.6.1 Mass spectrometry market revenue, by North America (USD Million)
5.5.6.2 Mass spectrometry market revenue, by Europe (USD Million)
5.5.6.3 Mass spectrometry market revenue, by Asia Pacific (USD Million)
5.5.6.4 Mass spectrometry market revenue, by Latin America (USD Million)
5.5.6.5 Mass spectrometry market revenue, by Middle-East & Africa (USD Million)
5.5.7 Real time PCR, 2014 to 2025
5.5.7.1 Real time PCR market revenue, by North America (USD Million)
5.5.7.2 Real time PCR market revenue, by Europe (USD Million)
5.5.7.3 Real time PCR market revenue, by Asia Pacific (USD Million)
5.5.7.4 Real time PCR market revenue, by Latin America (USD Million)
5.5.7.5 Real time PCR market revenue, by Middle-East & Africa (USD Million)
5.5.8 Microarray analysis, 2014 to 2025
5.5.8.1 Microarray analysis market revenue, by North America (USD Million)
5.5.8.2 Microarray analysis market revenue, by Europe (USD Million)
5.5.8.3 Microarray analysis market revenue, by Asia Pacific (USD Million)
5.5.8.4 Microarray analysis market revenue, by Latin America (USD Million)
5.2.8.5 Microarray analysis market revenue, by Middle-East & Africa (USD Million)
5.5.9 Statistical analysis, 2014 to 2025
5.5.9.1 Statistical analysis market revenue, by North America (USD Million)
5.5.9.2 Statistical analysis market revenue, by Europe (USD Million)
5.5.9.3 Statistical analysis market revenue, by Asia Pacific (USD Million)
5.5.9.4 Statistical analysis market revenue, by Latin America (USD Million)
5.5.9.5 Statistical analysis market revenue, by Middle-East & Africa (USD Million)
5.5.10 Bioinformatics, 2014 to 2025
5.5.10.1 Bioinformatics market revenue, by North America (USD Million)
5.5.10.2 Bioinformatics market revenue, by Europe (USD Million)
5.5.10.3 Bioinformatics market revenue, by Asia Pacific (USD Million)
5.5.10.4 Bioinformatics market revenue, by Latin America (USD Million)
5.5.10.5 Bioinformatics market revenue, by Middle-East & Africa (USD Million)
5.5.11 DNA sequencing, 2014 to 2025
5.5.11.1 DNA sequencing market revenue, by North America (USD Million)
5.5.11.2 DNA sequencing market revenue, by Europe (USD Million)
5.5.11.3 DNA sequencing market revenue, by Asia Pacific (USD Million)
5.5.11.4 DNA sequencing market revenue, by Latin America (USD Million)
5.5.11.5 DNA sequencing market revenue, by Middle-East & Africa (USD Million)
5.6 Others, 2014 to 2025
5.6.1 Others market revenue, by North America (USD Million)
5.6.2 Others market revenue, by Europe (USD Million)
5.6.3 Others market revenue, by Asia Pacific (USD Million)
5.6.4 Others market revenue, by Latin America (USD Million)
5.6.5 Others market revenue, by Middle-East & Africa (USD Million)
Chapter 6 Genomics Market Categorization: End-use Outlook
6.1 Genomics Market Share by End-Use, 2014 to 2025
6.2 Clinical & Research Laboratories, 2014 to 2025
6.2.1 Clinical & research laboratories market revenue, by North America (USD Million)
6.2.2 Clinical & research laboratories market revenue, by Europe (USD Million)
6.2.3 Clinical & research laboratories market revenue, by Asia Pacific (USD Million)
6.2.4 Clinical & research laboratories market revenue, by Latin America (USD Million)
6.2.5 Clinical & research laboratories market revenue, by Middle-East & Africa (USD Million)
6.3 Academic and Government Institutes, 2014 to 2025
6.3.1 Academic & government institutes market revenue, by North America (USD Million)
6.3.2 Academic & government institutes market revenue, by Europe (USD Million)
6.3.3 Academic & government institutes market revenue, by Asia Pacific (USD Million)
6.3.4 Academic & government institutes market revenue, by Latin America (USD Million)
6.3.5 Academic & government institutes market revenue, by Middle-East & Africa (USD Million)
6.4 Hospitals and Clinics, 2014 to 2025
6.4.1 Hospitals & clinics market revenue, by North America (USD Million)
6.4.2 Hospitals & clinics market revenue, by Europe (USD Million)
6.4.3 Hospitals & clinics market revenue, by Asia Pacific (USD Million)
6.4.4 Hospitals & clinics market revenue, by Latin America (USD Million)
6.4.5 Hospitals & clinics market revenue, by Middle-East & Africa (USD Million)
6.5 Pharmaceutical and Biotechnology Companies, 2014 to 2025
6.5.1 Pharmaceutical & biotechnology companies market revenue, by North America (USD Million)
6.5.2 Pharmaceutical & biotechnology companies market revenue, by Europe (USD Million)
6.5.3 Pharmaceutical & biotechnology companies market revenue, by Asia Pacific (USD Million)
6.5.4 Pharmaceutical & biotechnology companies market revenue, by Latin America (USD Million)
6.5.5 Pharmaceutical & biotechnology companies market revenue, by Middle-East & Africa (USD Million)
6.6 Other End Users, 2014 to 2025
6.6.1 Other end users market revenue, by North America (USD Million)
6.6.2 Other end users market revenue, by Europe (USD Million)
6.6.3 Other end users market revenue, by Asia Pacific (USD Million)
6.6.4 Other end users market revenue, by Latin America (USD Million)
6.6.5 Other end users market revenue, by Middle-East & Africa (USD Million)
Chapter 7 Genomics Market Categorization: Regional Outlook
7.1 Genomics Market Share By Region, 2014 to 2025
7.2 North America
7.2.1 Genomics market revenue, (USD Million), by U.S.
7.2.2 Genomics market revenue, (USD Million), by Canada
7.2.3 U.S.
7.2.3.1 Genomics market, by deliverables
7.2.3.2 Genomics market, by application & technology
7.2.3.3 Genomics market, by end-use
7.2.4 Canada
7.2.4.1 Genomics market, by deliverables
7.2.4.2 Genomics market, by application & technology
7.2.4.3 Genomics market, by end-use
7.3 Europe
7.3.1 Genomics market revenue, (USD Million), by Germany
7.3.2 Genomics market revenue, (USD Million), by U.K.
7.3.3 Germany
7.3.3.1 Genomics market, by deliverables
7.3.3.2 Genomics market, by application & technology
7.3.3.3 Genomics market, by end-use
7.3.4 U.K.
7.3.4.1 Genomics market, by deliverables
7.3.4.2 Genomics market, by application & technology
7.3.4.3 Genomics market, by end-use
7.4 Asia Pacific
7.4.1 Genomics market revenue, (USD Million), by Germany
7.4.2 Genomics market revenue, (USD Million), by U.K.
7.4.3 Japan
7.4.3.1 Genomics market, by deliverables
7.4.3.2 Genomics market, by application & technology
7.4.3.3 Genomics market, by end-use
7.4.4 China
7.4.4.1 Genomics market, by deliverables
7.4.4.2 Genomics market, by application & technology
7.4.4.3 Genomics market, by end-use
7.5 Latin America
7.5.1 Genomics market revenue, (USD Million), by Brazil
7.5.2 Brazil
7.5.2.1 Genomics market, by deliverables
7.5.2.2 Genomics market, by application & technology
7.5.2.3 Genomics market, by end-use
7.6 MEA
7.6.1 Genomics market revenue, (USD Million), by MEA
7.6.2 South Africa
7.6.2.1 Genomics market, by deliverables
7.6.2.2 Genomics market, by application & technology
7.6.2.3 Genomics market, by end-use
List of Tables
TABLE 1 Gene discoveries and its application in personalized treatment for neurologic diseases
TABLE 2 North America genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 3 North America genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 4 North America genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 5 North America genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 6 North America functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 7 North America epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 8 North America pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 9 North America biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 10 U.S. genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 11 U.S. genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 12 U.S. genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 13 U.S. genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 14 U.S. functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 15 U.S. epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 16 U.S. pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 17 U.S. biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 18 Canada genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 19 Canada genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 20 Canada genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 21 Canada genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 22 Canada functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 23 Canada epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 24 Canada pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 25 Canada biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 26 Europe genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 27 Europe genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 28 Europe genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 29 Europe genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 30 Europe functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 31 Europe epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 32 Europe pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 33 Europe biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 34 Germany genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 35 Germany genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 36 Germany genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 37 Germany genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 38 Germany functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 39 Germany epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 40 Germany pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 41 Germany biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 42 U.K. genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 43 U.K. genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 44 U.K. genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 45 U.K. genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 46 U.K. functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 47 U.K. epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 48 U.K. pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 49 U.K. biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 50 Asia Pacific genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 51 Asia Pacific genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 52 Asia Pacific genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 53 Asia Pacific genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 54 Asia Pacific functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 55 Asia Pacific epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 56 Asia Pacific pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 57 Asia Pacific biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 58 Japan genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 59 Japan genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 60 Japan genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 61 Japan genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 62 Japan functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 63 Japan epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 64 Japan pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 65 Japan biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 66 China genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 67 China genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)
TABLE 68 China genomics services market estimates & forecasts, 2014 - 2025 (USD Million)
TABLE 69 China genomics market estimates & forecasts, by technology, 2014 - 2025 (USD Million)
TABLE 70 China functional genomics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 71 China epigenetics market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 72 China pathway analysis market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 73 China biomarker discovery market estimates & forecasts, by application, 2014 - 2025 (USD Million)
TABLE 74 Latin America genomics market estimates & forecasts, by products & services, 2014 - 2025 (USD Million)
TABLE 75 Latin America genomics market estimates & forecasts, by products, 2014 - 2025 (USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report